Position
Chairman
Company
Juvisé Pharmaceuticals
ParisBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalDescription
Juvisé Pharmaceuticals has officially appointed Renaud Sermondade as the new CEO, effective July 1, 2026, while Frédéric Mascha assumes the role of Executive Chairman. This leadership transition aims to support the company's strategic growth and international expansion.
Quick answer
Juvisé Pharmaceuticals Appoints Renaud Sermondade as CEO (April 16, 2026). Juvisé Pharmaceuticals is based in Paris, Ile-de-France, France.
- What did Juvisé Pharmaceuticals announce on April 16, 2026?
- Juvisé Pharmaceuticals has officially appointed Renaud Sermondade as the new CEO, effective July 1, 2026, while Frédéric Mascha assumes the role of Executive Chairman. This leadership transition aims to support the company's strategic growth and international expansion.
- What does Juvisé Pharmaceuticals do?
- Juvisé Pharmaceuticals, based in Paris, France, is a leading pharmaceutical company with a focus on enhancing patient care by providing access to treatments with high medical value.
- Where is Juvisé Pharmaceuticals based?
- Juvisé Pharmaceuticals is based in Paris, Ile-de-France, France.
- Which similar companies made leadership changes around the same time?
- NRx Pharmaceuticals (April 13, 2026), Abivax (April 12, 2026), Vanda Pharmaceuticals (April 2, 2026) and Radius (May 2, 2026) also announced leadership changes within 45 days of Juvisé Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
- Vanda Pharmaceuticals Inc. Announces Resignation of Senior Executive (April 2, 2026)
- Radius Promotes Jonathan Haseler to Divisional Chief Executive Officer for Fuel and EV (May 2, 2026)
- Menarini Group Appoints Thomas Cueni as New Director (May 7, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
Who to call at Juvisé Pharmaceuticals, and when
A new leader at Juvisé Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Juvisé Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Juvisé Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Juvisé Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Juvisé Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Juvisé Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.